A First in Man Study to Determine the Safety at Various Dose Levels of AGS-16M8F in Advanced Kidney Cancer

Sponsor and Collaborators     

Astellas Pharma Inc
Agensys, Inc


Continue Reading

Contact
Agensys Clinical Reasearch and Development         
[email protected]    
310-820-8029
    
Investigator    
Chief Medical Officer     
Agensys, Inc.

ClinicalTrials.gov Identifier

NCT01114230